Amylyx shareholders elect three Class I directors; ratify Deloitte; approve say-on-pay proposal

Amylyx Pharmaceuticals, Inc.

Karen Firestone, Justin Klee, and Bernhardt Zeiher elected as Class I directors for term ending 2028. Firestone and Zeiher each had ~21.3M votes withheld; Klee had 1.5M.
Ratification of Deloitte & Touche as auditor for FY 2025 passed with 72.5M for vs 34.7K against.
Non-binding advisory vote on executive compensation passed with 33.1M for, 24.1M against, and 2.0M abstentions.
Total shares voted: ~72.5M on auditor proposal; broker non-votes of 15.4M on director elections and say-on-pay.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.